• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LNSR

LNSR

LENSAR, Inc.

NASDAQHealthcareMedical - DevicesUS

USD5.74

+0.00 (+0.00%)

Rating:B+

Company Profile

CEO

Nicholas T. Curtis

IPO Date

2020-10-02

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.85

Prev. Close

$5.74

Day Low

$5.64

Day High

$5.90

52W Low

$5.06

52W High

$13.67

Market Cap

$0.07B

Volume

0.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

4

Avg Positive

6.5%

Avg Negative

4.0%

Avg Neutral

89.0%

News Feed

LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting

Business Wire·7/15/2021·↑ positive

LENSAR, Inc. (LNSR) CEO Nick Curtis on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

LENSAR's (LNSR) CEO Nick Curtis on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/10/2021·↓ negative

LENSAR to Present at Two Upcoming Investor Conferences

Business Wire·2/8/2021·↑ positive